FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I Inhibitor, Shows Potent Antitumor Activity in Preclinical Models
FZ-AD005 是一种新型 DLL3 靶向抗体药物偶联物,含有拓扑异构酶 I 抑制剂,在临床前模型中表现出强效抗肿瘤活性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-23-0701
Qingsong Guo, Bei Gao, Ruiwen Song, Weinan Li, Shulei Zhu, Qian Xie, Sensen Lou, Lei Wang, Jiafei Shen, Teng Zhao, Yifan Zhang, Jinsong Wu, Wei Lu, Tong Yang